<DOC>
	<DOCNO>NCT00802087</DOCNO>
	<brief_summary>The purpose study evaluate pharmacokinetic profile different Egalet® hydrocodone formulation compare market hydrocodone drug .</brief_summary>
	<brief_title>Single Dose Pharmacokinetics Egalet® Hydrocodone</brief_title>
	<detailed_description>Outcomes : Pharmacokinetic parameter bioequivalence testing .</detailed_description>
	<mesh_term>Hydrocodone</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>Nonsmokers ≥18 ≤55 year age BMI ≥19 ≤30.0 Clinically significant abnormality , physical psychological illness condition contraindicate hydrocodone treatment History significant abuse , dependance addiction alcohol , drug hard drug within one year prior screen Allergic hydrocodone , hydromorphone , opioids , relate drug Use drug know induce inhibit hepatic drug metabolism within 30 day prior study drug administration Pregnant breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Hydrocodone</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Safety &amp; Tolerability</keyword>
</DOC>